-
Clinical trial end points relevant to patients and society for rare cancers
Shelize Khakoo, Alexandros Georgiou & Ian Chau
Clinical Trail Methodology: Clinical Investigation
-
Clinical trial end points relevant to patients and society for rare cancers
Shelize Khakoo, Alexandros Georgiou & Ian Chau
Clinical Trail Methodology: Clinical Investigation
-
Clinical trial end points relevant to patients and society for rare cancers
Shelize Khakoo, Alexandros Georgiou & Ian Chau
Clinical Trail Methodology: Clinical Investigation
-
Clinical trial end points relevant to patients and society for rare cancers
Shelize Khakoo, Alexandros Georgiou & Ian Chau
Clinical Trail Methodology: Clinical Investigation
-
Clinical trial end points relevant to patients and society for rare cancers
Shelize Khakoo, Alexandros Georgiou & Ian Chau
Clinical Trail Methodology: Clinical Investigation
-
Clinical trial end points relevant to patients and society for rare cancers
Shelize Khakoo, Alexandros Georgiou & Ian Chau
Clinical Trail Methodology: Clinical Investigation
-
Clinical trial end points relevant to patients and society for rare cancers
Shelize Khakoo, Alexandros Georgiou & Ian Chau
Clinical Trail Methodology: Clinical Investigation
-
Clinical trial end points relevant to patients and society for rare cancers
Shelize Khakoo, Alexandros Georgiou & Ian Chau
Clinical Trail Methodology: Clinical Investigation
-
Evidence-based therapy for the ANCA associated vasculitides: what do the trials show so far?
Lovesh Dyall , Dimitrios Chanouzas & Matthew David Morgan
Clinical Trail Outcomes: Clinical Investigation
-
Evidence-based therapy for the ANCA associated vasculitides: what do the trials show so far?
Lovesh Dyall , Dimitrios Chanouzas & Matthew David Morgan
Clinical Trail Outcomes: Clinical Investigation
-
Evidence-based therapy for the ANCA associated vasculitides: what do the trials show so far?
Lovesh Dyall , Dimitrios Chanouzas & Matthew David Morgan
Clinical Trail Outcomes: Clinical Investigation
-
Evidence-based therapy for the ANCA associated vasculitides: what do the trials show so far?
Lovesh Dyall , Dimitrios Chanouzas & Matthew David Morgan
Clinical Trail Outcomes: Clinical Investigation
-
Evidence-based therapy for the ANCA associated vasculitides: what do the trials show so far?
Lovesh Dyall , Dimitrios Chanouzas & Matthew David Morgan
Clinical Trail Outcomes: Clinical Investigation
-
Evidence-based therapy for the ANCA associated vasculitides: what do the trials show so far?
Lovesh Dyall , Dimitrios Chanouzas & Matthew David Morgan
Clinical Trail Outcomes: Clinical Investigation
-
Evidence-based therapy for the ANCA associated vasculitides: what do the trials show so far?
Lovesh Dyall , Dimitrios Chanouzas & Matthew David Morgan
Clinical Trail Outcomes: Clinical Investigation
-
Evidence-based therapy for the ANCA associated vasculitides: what do the trials show so far?
Lovesh Dyall , Dimitrios Chanouzas & Matthew David Morgan
Clinical Trail Outcomes: Clinical Investigation
-
Inclusion of patients with brain metastases in clinical trials
Lauren E Abrey
Editorial: Clinical Investigation
-
Inclusion of patients with brain metastases in clinical trials
Lauren E Abrey
Editorial: Clinical Investigation
-
Inclusion of patients with brain metastases in clinical trials
Lauren E Abrey
Editorial: Clinical Investigation
-
Inclusion of patients with brain metastases in clinical trials
Lauren E Abrey
Editorial: Clinical Investigation
-
Inclusion of patients with brain metastases in clinical trials
Lauren E Abrey
Editorial: Clinical Investigation
-
Inclusion of patients with brain metastases in clinical trials
Lauren E Abrey
Editorial: Clinical Investigation
-
Inclusion of patients with brain metastases in clinical trials
Lauren E Abrey
Editorial: Clinical Investigation
-
Inclusion of patients with brain metastases in clinical trials
Lauren E Abrey
Editorial: Clinical Investigation
-
Challenges and prospects for stem cell-based therapy in Type 1 diabetes
News and Views: Clinical Investigation
-
Challenges and prospects for stem cell-based therapy in Type 1 diabetes
News and Views: Clinical Investigation
-
Challenges and prospects for stem cell-based therapy in Type 1 diabetes
News and Views: Clinical Investigation
-
Challenges and prospects for stem cell-based therapy in Type 1 diabetes
News and Views: Clinical Investigation
-
Challenges and prospects for stem cell-based therapy in Type 1 diabetes
News and Views: Clinical Investigation
-
Challenges and prospects for stem cell-based therapy in Type 1 diabetes
News and Views: Clinical Investigation
-
Challenges and prospects for stem cell-based therapy in Type 1 diabetes
News and Views: Clinical Investigation
-
Challenges and prospects for stem cell-based therapy in Type 1 diabetes
News and Views: Clinical Investigation
-
The IMPROVE-IT trial: current status and potential clinical implications of ezetimibe
Finn Akerstrm, Luis Rodriguez-Padial
Review Article: Clinical Investigation
-
The IMPROVE-IT trial: current status and potential clinical implications of ezetimibe
Finn Akerstrm, Luis Rodriguez-Padial
Review Article: Clinical Investigation
-
The IMPROVE-IT trial: current status and potential clinical implications of ezetimibe
Finn Akerstrm, Luis Rodriguez-Padial
Review Article: Clinical Investigation
-
The IMPROVE-IT trial: current status and potential clinical implications of ezetimibe
Finn Akerstrm, Luis Rodriguez-Padial
Review Article: Clinical Investigation
-
The IMPROVE-IT trial: current status and potential clinical implications of ezetimibe
Finn Akerstrm, Luis Rodriguez-Padial
Review Article: Clinical Investigation
-
The IMPROVE-IT trial: current status and potential clinical implications of ezetimibe
Finn Akerstrm, Luis Rodriguez-Padial
Review Article: Clinical Investigation
-
The IMPROVE-IT trial: current status and potential clinical implications of ezetimibe
Finn Akerstrm, Luis Rodriguez-Padial
Review Article: Clinical Investigation
-
The IMPROVE-IT trial: current status and potential clinical implications of ezetimibe
Finn Akerstrm, Luis Rodriguez-Padial
Review Article: Clinical Investigation